Related Experiment Video

Updated: May 9, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.7K

Electroencephalography, microRNA, and anti-NMDA receptor encephalitis

Hsiuying Wang1

  • 1Institute of Statistics, National Yang Ming Chiao Tung University, Hsinchu 300093, Taiwan.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|December 26, 2025
PubMed

Insights

Early diagnosis of autoimmune anti-N-methyl-d-aspartate receptor encephalitis (anti-NMDARE) is crucial. Combining electroencephalography (EEG) and microRNA (miRNA) biomarkers improves diagnosis and prognosis for this severe brain disorder.

Area of Science:

  • Neuroscience
  • Immunology
  • Biomarker Discovery

Background:

  • Anti-N-methyl-d-aspartate receptor encephalitis (anti-NMDARE) is a severe autoimmune condition affecting the brain.
  • Early diagnosis of anti-NMDARE is critical for effective treatment and improved patient outcomes.
  • Current diagnostic approaches rely on antibody detection and clinical symptoms.

Purpose of the Study:

  • To review the characteristic electroencephalography (EEG) patterns in anti-NMDARE.
  • To explore the potential of microRNA (miRNA) biomarkers for diagnosing and predicting the prognosis of anti-NMDARE.
  • To emphasize the value of integrating EEG and miRNA biomarkers for comprehensive clinical assessment.

Main Methods:

  • Review of existing literature on EEG features in anti-NMDARE.
  • Analysis of studies investigating miRNA profiles in anti-NMDARE patients.
  • Synthesis of findings regarding the combined utility of EEG and miRNA biomarkers.

Main Results:

  • Distinct EEG patterns, including extreme delta brush and generalized rhythmic delta activity, are hallmarks of anti-NMDARE.
  • Specific miRNAs show potential as diagnostic and prognostic indicators for anti-NMDARE.
  • Both EEG and miRNA biomarkers offer valuable insights into patient status.

Conclusions:

  • EEG is a vital clinical tool for the early identification of anti-NMDARE.
  • miRNA biomarkers present a promising avenue for enhancing anti-NMDARE diagnosis and prognosis.
  • Combining EEG and miRNA biomarkers is recommended for more accurate and timely clinical assessment and management of anti-NMDARE.
Keywords:
Anti-NMDA receptor encephalitisAutoimmune disorderElectroencephalographyExtreme delta brushGeneralized rhythmic delta activitymicroRNA

More Related Videos

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

10.3K
Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis08:20

Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis

Published on: June 2, 2022

3.8K

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...